 Brent Palmer
Concepts (452)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 37 | 2024 | 2721 | 3.740 |
Why?
| | CD4-Positive T-Lymphocytes | 34 | 2021 | 1056 | 3.440 |
Why?
| | Gastrointestinal Microbiome | 8 | 2024 | 640 | 1.940 |
Why?
| | Homosexuality, Male | 4 | 2022 | 176 | 1.530 |
Why?
| | Microbiota | 8 | 2024 | 729 | 1.510 |
Why?
| | HIV-1 | 17 | 2018 | 837 | 1.460 |
Why?
| | Sexual and Gender Minorities | 4 | 2022 | 195 | 1.400 |
Why?
| | HIV | 5 | 2019 | 227 | 1.320 |
Why?
| | Programmed Cell Death 1 Receptor | 11 | 2019 | 232 | 1.170 |
Why?
| | Inflammation | 9 | 2024 | 2737 | 1.060 |
Why?
| | Dysbiosis | 3 | 2021 | 169 | 0.990 |
Why?
| | Virus Replication | 5 | 2010 | 450 | 0.940 |
Why?
| | Epitopes, T-Lymphocyte | 6 | 2010 | 186 | 0.910 |
Why?
| | Receptors, CCR5 | 4 | 2021 | 57 | 0.900 |
Why?
| | Lymphocyte Activation | 16 | 2018 | 1109 | 0.900 |
Why?
| | CD8-Positive T-Lymphocytes | 16 | 2021 | 857 | 0.850 |
Why?
| | Feces | 4 | 2021 | 441 | 0.830 |
Why?
| | Antigens, CD | 9 | 2020 | 489 | 0.780 |
Why?
| | Berylliosis | 6 | 2013 | 185 | 0.770 |
Why?
| | Gastrointestinal Tract | 2 | 2014 | 185 | 0.740 |
Why?
| | Viral Load | 9 | 2020 | 448 | 0.730 |
Why?
| | Firmicutes | 1 | 2021 | 18 | 0.710 |
Why?
| | Macrophages, Alveolar | 3 | 2020 | 389 | 0.700 |
Why?
| | Antiretroviral Therapy, Highly Active | 7 | 2016 | 267 | 0.670 |
Why?
| | T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2020 | 7 | 0.670 |
Why?
| | Anti-Inflammatory Agents | 3 | 2022 | 480 | 0.670 |
Why?
| | Up-Regulation | 9 | 2019 | 839 | 0.660 |
Why?
| | Germ-Free Life | 1 | 2019 | 33 | 0.630 |
Why?
| | Varicellovirus | 4 | 2022 | 17 | 0.620 |
Why?
| | Apoptosis Regulatory Proteins | 3 | 2008 | 182 | 0.600 |
Why?
| | Leukocytes, Mononuclear | 7 | 2022 | 545 | 0.600 |
Why?
| | T-Lymphocyte Subsets | 10 | 2016 | 412 | 0.560 |
Why?
| | CD57 Antigens | 3 | 2007 | 16 | 0.550 |
Why?
| | Anti-HIV Agents | 5 | 2016 | 754 | 0.540 |
Why?
| | Beryllium | 6 | 2009 | 152 | 0.530 |
Why?
| | B7-H1 Antigen | 6 | 2019 | 195 | 0.520 |
Why?
| | Cytokines | 12 | 2021 | 2013 | 0.510 |
Why?
| | Interferon-gamma | 13 | 2013 | 772 | 0.510 |
Why?
| | Lung | 16 | 2022 | 3927 | 0.500 |
Why?
| | Intestinal Mucosa | 1 | 2021 | 589 | 0.490 |
Why?
| | Humans | 85 | 2024 | 129271 | 0.480 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2016 | 99 | 0.480 |
Why?
| | Bacteria | 4 | 2022 | 813 | 0.480 |
Why?
| | Viremia | 5 | 2018 | 131 | 0.460 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2022 | 1202 | 0.450 |
Why?
| | T-Lymphocytes, Regulatory | 7 | 2021 | 373 | 0.450 |
Why?
| | Biota | 1 | 2013 | 31 | 0.420 |
Why?
| | B-Lymphocytes | 7 | 2022 | 815 | 0.410 |
Why?
| | Immunophenotyping | 9 | 2020 | 310 | 0.400 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2020 | 644 | 0.400 |
Why?
| | Herpesviridae Infections | 4 | 2019 | 141 | 0.400 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 2 | 2009 | 26 | 0.390 |
Why?
| | T-Lymphocytes | 9 | 2018 | 1933 | 0.380 |
Why?
| | Anti-Retroviral Agents | 4 | 2024 | 231 | 0.370 |
Why?
| | Down-Regulation | 2 | 2016 | 636 | 0.370 |
Why?
| | Herpes Zoster | 4 | 2022 | 317 | 0.350 |
Why?
| | Interleukin-2 | 5 | 2013 | 437 | 0.350 |
Why?
| | Herpesvirus 3, Human | 4 | 2022 | 331 | 0.350 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2019 | 522 | 0.340 |
Why?
| | Adult | 29 | 2020 | 35497 | 0.330 |
Why?
| | Gene Products, gag | 3 | 2016 | 36 | 0.320 |
Why?
| | Receptors, OX40 | 1 | 2009 | 15 | 0.320 |
Why?
| | Interleukin-10 | 4 | 2022 | 300 | 0.310 |
Why?
| | Male | 34 | 2022 | 63517 | 0.300 |
Why?
| | Middle Aged | 25 | 2020 | 31091 | 0.300 |
Why?
| | Antibodies, Viral | 4 | 2022 | 601 | 0.300 |
Why?
| | Virus Activation | 3 | 2019 | 88 | 0.290 |
Why?
| | Membrane Proteins | 3 | 2013 | 1117 | 0.290 |
Why?
| | Chronic Disease | 9 | 2014 | 1716 | 0.290 |
Why?
| | Immune System | 2 | 2019 | 175 | 0.290 |
Why?
| | Vitiligo | 2 | 2019 | 41 | 0.280 |
Why?
| | Meningitis, Cryptococcal | 2 | 2020 | 30 | 0.280 |
Why?
| | Dendritic Cells | 8 | 2019 | 479 | 0.280 |
Why?
| | Immunologic Factors | 2 | 2022 | 230 | 0.280 |
Why?
| | Vaccination | 3 | 2021 | 1347 | 0.280 |
Why?
| | Cerebrospinal Fluid | 2 | 2020 | 91 | 0.270 |
Why?
| | Interleukin-1 | 3 | 2019 | 959 | 0.270 |
Why?
| | Mice | 18 | 2024 | 16915 | 0.260 |
Why?
| | Sexual Behavior | 3 | 2020 | 481 | 0.260 |
Why?
| | Female | 33 | 2023 | 68556 | 0.260 |
Why?
| | Cohort Studies | 8 | 2019 | 5409 | 0.260 |
Why?
| | Animals | 26 | 2024 | 35309 | 0.260 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2010 | 704 | 0.250 |
Why?
| | Gene Expression | 1 | 2010 | 1466 | 0.240 |
Why?
| | DNA, Bacterial | 2 | 2019 | 321 | 0.240 |
Why?
| | Immunity, Innate | 3 | 2019 | 803 | 0.240 |
Why?
| | Host-Pathogen Interactions | 3 | 2024 | 351 | 0.240 |
Why?
| | Interleukin-12 | 2 | 2022 | 118 | 0.220 |
Why?
| | Autoimmune Diseases | 2 | 2019 | 426 | 0.210 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 11 | 0.210 |
Why?
| | Cell Proliferation | 8 | 2010 | 2375 | 0.210 |
Why?
| | Interleukin-6 | 3 | 2022 | 720 | 0.210 |
Why?
| | Disease Models, Animal | 7 | 2024 | 4057 | 0.210 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 29 | 0.200 |
Why?
| | Young Adult | 9 | 2020 | 12392 | 0.200 |
Why?
| | Smokers | 2 | 2020 | 138 | 0.200 |
Why?
| | Flow Cytometry | 9 | 2015 | 1155 | 0.200 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2022 | 135 | 0.200 |
Why?
| | Peripheral Tolerance | 1 | 2022 | 15 | 0.190 |
Why?
| | HIV Core Protein p24 | 5 | 2010 | 31 | 0.190 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 147 | 0.190 |
Why?
| | Lymph Nodes | 3 | 2019 | 470 | 0.190 |
Why?
| | Exanthema | 1 | 2022 | 74 | 0.190 |
Why?
| | Monocytes | 4 | 2019 | 551 | 0.190 |
Why?
| | Killer Cells, Natural | 3 | 2014 | 427 | 0.180 |
Why?
| | Chickenpox | 1 | 2022 | 80 | 0.180 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 240 | 0.180 |
Why?
| | Immunologic Memory | 6 | 2014 | 349 | 0.180 |
Why?
| | Polysaccharides, Bacterial | 2 | 2022 | 67 | 0.180 |
Why?
| | Immunity, Humoral | 1 | 2021 | 118 | 0.170 |
Why?
| | Macaca mulatta | 5 | 2022 | 149 | 0.170 |
Why?
| | Lung Diseases | 3 | 2017 | 739 | 0.170 |
Why?
| | Lymphocyte Depletion | 3 | 2019 | 131 | 0.170 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 4 | 2019 | 30 | 0.170 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 107 | 0.170 |
Why?
| | Integrin alpha Chains | 1 | 2020 | 23 | 0.170 |
Why?
| | Cell Compartmentation | 1 | 2020 | 52 | 0.170 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2021 | 64 | 0.170 |
Why?
| | Pneumocystis | 2 | 1996 | 11 | 0.170 |
Why?
| | Haplotypes | 2 | 2019 | 475 | 0.160 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 149 | 0.160 |
Why?
| | Genome, Bacterial | 1 | 2021 | 134 | 0.160 |
Why?
| | Toll-Like Receptors | 2 | 2018 | 179 | 0.160 |
Why?
| | Fetal Blood | 2 | 2014 | 317 | 0.160 |
Why?
| | Cells, Cultured | 9 | 2016 | 4077 | 0.160 |
Why?
| | HLA-DR Antigens | 4 | 2016 | 223 | 0.160 |
Why?
| | CD4 Lymphocyte Count | 4 | 2013 | 266 | 0.160 |
Why?
| | Hexosaminidases | 1 | 2019 | 18 | 0.160 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 179 | 0.160 |
Why?
| | Audiovisual Aids | 1 | 2019 | 13 | 0.160 |
Why?
| | Prevotella | 1 | 2018 | 14 | 0.150 |
Why?
| | Genes, MHC Class II | 1 | 2019 | 73 | 0.150 |
Why?
| | Disease | 1 | 2019 | 95 | 0.150 |
Why?
| | Multiple Myeloma | 1 | 2020 | 125 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2023 | 493 | 0.150 |
Why?
| | Emtricitabine | 2 | 2016 | 168 | 0.150 |
Why?
| | Virus Latency | 1 | 2019 | 84 | 0.150 |
Why?
| | Monkey Diseases | 1 | 2018 | 20 | 0.150 |
Why?
| | Fluorescent Antibody Technique | 4 | 2015 | 376 | 0.150 |
Why?
| | Green Fluorescent Proteins | 2 | 2018 | 385 | 0.140 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 117 | 0.140 |
Why?
| | Tenofovir | 2 | 2016 | 231 | 0.140 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 422 | 0.140 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2015 | 220 | 0.140 |
Why?
| | Colon | 1 | 2020 | 252 | 0.140 |
Why?
| | Aged | 11 | 2019 | 22032 | 0.140 |
Why?
| | Open Reading Frames | 1 | 2018 | 116 | 0.140 |
Why?
| | CTLA-4 Antigen | 2 | 2019 | 87 | 0.140 |
Why?
| | Pneumonia, Pneumocystis | 2 | 1996 | 35 | 0.140 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2018 | 90 | 0.140 |
Why?
| | Principal Component Analysis | 1 | 2018 | 190 | 0.140 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1085 | 0.140 |
Why?
| | Case-Control Studies | 7 | 2020 | 3377 | 0.130 |
Why?
| | Vaccines, DNA | 1 | 2016 | 28 | 0.130 |
Why?
| | Genitalia | 1 | 2016 | 30 | 0.130 |
Why?
| | Skin | 2 | 2019 | 726 | 0.130 |
Why?
| | Melanoma | 3 | 2008 | 729 | 0.130 |
Why?
| | Immunization, Secondary | 1 | 2016 | 87 | 0.130 |
Why?
| | Antigen Presentation | 1 | 2017 | 207 | 0.130 |
Why?
| | Biopsy | 1 | 2020 | 1092 | 0.130 |
Why?
| | Withholding Treatment | 1 | 2016 | 71 | 0.130 |
Why?
| | Mice, Knockout | 5 | 2021 | 2871 | 0.130 |
Why?
| | Immune Tolerance | 2 | 2016 | 355 | 0.130 |
Why?
| | Hepatitis C | 2 | 2009 | 238 | 0.120 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2016 | 363 | 0.120 |
Why?
| | Mouth | 1 | 2015 | 84 | 0.120 |
Why?
| | Retroviridae Infections | 1 | 2015 | 46 | 0.120 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 207 | 0.120 |
Why?
| | Cytomegalovirus Infections | 2 | 2015 | 189 | 0.120 |
Why?
| | Immune Evasion | 1 | 2015 | 56 | 0.120 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2016 | 200 | 0.120 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 400 | 0.120 |
Why?
| | Rectum | 1 | 2016 | 170 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2018 | 505 | 0.120 |
Why?
| | Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 18 | 0.120 |
Why?
| | Survivors | 2 | 2016 | 457 | 0.120 |
Why?
| | Software | 1 | 2019 | 606 | 0.110 |
Why?
| | Organophosphonates | 1 | 2015 | 92 | 0.110 |
Why?
| | Immunotherapy | 1 | 2019 | 592 | 0.110 |
Why?
| | Adolescent | 5 | 2020 | 20315 | 0.110 |
Why?
| | Mortality | 1 | 2016 | 307 | 0.110 |
Why?
| | Immunization | 2 | 2008 | 411 | 0.110 |
Why?
| | Receptors, Interleukin-1 | 1 | 2015 | 218 | 0.110 |
Why?
| | Deoxycytidine | 1 | 2015 | 165 | 0.110 |
Why?
| | Macrophages | 4 | 2015 | 1484 | 0.110 |
Why?
| | Physical Fitness | 1 | 2015 | 203 | 0.110 |
Why?
| | DNA, Ribosomal | 1 | 2013 | 83 | 0.110 |
Why?
| | Tropheryma | 1 | 2013 | 5 | 0.110 |
Why?
| | Whipple Disease | 1 | 2013 | 6 | 0.110 |
Why?
| | Biomarkers | 6 | 2019 | 3968 | 0.100 |
Why?
| | Leukocyte Common Antigens | 3 | 2011 | 82 | 0.100 |
Why?
| | Adenine | 1 | 2015 | 256 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1499 | 0.100 |
Why?
| | Galectins | 1 | 2013 | 22 | 0.100 |
Why?
| | Mice, Inbred BALB C | 3 | 2012 | 1247 | 0.100 |
Why?
| | 4-1BB Ligand | 2 | 2009 | 7 | 0.100 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2015 | 203 | 0.100 |
Why?
| | Hematopoiesis | 2 | 2011 | 183 | 0.100 |
Why?
| | Cytomegalovirus | 3 | 2015 | 154 | 0.100 |
Why?
| | Interleukins | 1 | 2013 | 241 | 0.100 |
Why?
| | Receptors, CXCR4 | 2 | 2010 | 83 | 0.100 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 296 | 0.090 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 776 | 0.090 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2011 | 14 | 0.090 |
Why?
| | Prognosis | 2 | 2017 | 3773 | 0.090 |
Why?
| | RNA, Viral | 3 | 2004 | 619 | 0.090 |
Why?
| | Th1 Cells | 2 | 2013 | 137 | 0.090 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 983 | 0.090 |
Why?
| | Cell Line | 5 | 2018 | 2779 | 0.090 |
Why?
| | Motor Activity | 1 | 2015 | 675 | 0.090 |
Why?
| | CCR5 Receptor Antagonists | 1 | 2010 | 6 | 0.090 |
Why?
| | Metagenome | 1 | 2011 | 140 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2276 | 0.080 |
Why?
| | Forkhead Transcription Factors | 2 | 2010 | 184 | 0.080 |
Why?
| | Lymphocyte Count | 4 | 2017 | 148 | 0.080 |
Why?
| | Ecology | 1 | 2011 | 108 | 0.080 |
Why?
| | Ligands | 2 | 2014 | 621 | 0.080 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2835 | 0.080 |
Why?
| | Hydroxamic Acids | 1 | 2010 | 88 | 0.080 |
Why?
| | Skin Neoplasms | 2 | 2007 | 824 | 0.080 |
Why?
| | OX40 Ligand | 1 | 2009 | 10 | 0.080 |
Why?
| | Cell Lineage | 1 | 2011 | 332 | 0.080 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2007 | 135 | 0.080 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2009 | 28 | 0.080 |
Why?
| | Vagina | 1 | 2011 | 174 | 0.080 |
Why?
| | Antibodies, Monoclonal | 5 | 2020 | 1367 | 0.080 |
Why?
| | Risk Factors | 2 | 2020 | 9746 | 0.080 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 1049 | 0.080 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 86 | 0.080 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2010 | 209 | 0.070 |
Why?
| | Myeloid Cells | 1 | 2009 | 141 | 0.070 |
Why?
| | Convalescence | 1 | 2007 | 18 | 0.070 |
Why?
| | Cell Division | 2 | 2013 | 796 | 0.070 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 33 | 0.070 |
Why?
| | Genes, rev | 1 | 2007 | 2 | 0.070 |
Why?
| | Genes, tat | 1 | 2007 | 3 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2011 | 495 | 0.070 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2537 | 0.070 |
Why?
| | Arthritis, Experimental | 1 | 2009 | 135 | 0.070 |
Why?
| | Tumor Escape | 1 | 2007 | 39 | 0.070 |
Why?
| | Cystatins | 1 | 2006 | 6 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 1 | 2007 | 92 | 0.070 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2006 | 100 | 0.060 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2007 | 97 | 0.060 |
Why?
| | Prospective Studies | 4 | 2016 | 7123 | 0.060 |
Why?
| | Ecosystem | 1 | 2011 | 556 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2009 | 1288 | 0.060 |
Why?
| | RNA, Catalytic | 1 | 2007 | 185 | 0.060 |
Why?
| | Interleukin-1beta | 2 | 2021 | 372 | 0.060 |
Why?
| | Receptors, CCR7 | 1 | 2005 | 27 | 0.060 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2023 | 572 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 45 | 0.060 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2005 | 51 | 0.060 |
Why?
| | Hepacivirus | 1 | 2007 | 235 | 0.060 |
Why?
| | Signal Transduction | 4 | 2021 | 4926 | 0.060 |
Why?
| | Hepatitis C, Chronic | 1 | 2007 | 153 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2007 | 591 | 0.060 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 2 | 2019 | 14 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2342 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2015 | 328 | 0.060 |
Why?
| | United States | 1 | 2021 | 13828 | 0.060 |
Why?
| | Neoplasms | 1 | 2019 | 2449 | 0.060 |
Why?
| | Antigens, CD34 | 3 | 2011 | 88 | 0.060 |
Why?
| | Zimbabwe | 1 | 2024 | 53 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2019 | 5439 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2011 | 1446 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2019 | 877 | 0.050 |
Why?
| | Pulmonary Fibrosis | 1 | 2006 | 384 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 34 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 29 | 0.050 |
Why?
| | CD4 Antigens | 3 | 2007 | 138 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2015 | 1887 | 0.050 |
Why?
| | Bacteroides fragilis | 1 | 2022 | 13 | 0.050 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 88 | 0.050 |
Why?
| | Lectins, C-Type | 1 | 2002 | 71 | 0.050 |
Why?
| | Allergens | 1 | 2005 | 385 | 0.050 |
Why?
| | Hypersensitivity | 1 | 2005 | 248 | 0.050 |
Why?
| | Mice, SCID | 2 | 2007 | 350 | 0.050 |
Why?
| | Cell Count | 2 | 2016 | 311 | 0.050 |
Why?
| | Longitudinal Studies | 3 | 2018 | 2716 | 0.050 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2002 | 227 | 0.050 |
Why?
| | CD28 Antigens | 2 | 2013 | 48 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2003 | 336 | 0.050 |
Why?
| | Interferons | 1 | 2022 | 193 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 126 | 0.040 |
Why?
| | Transforming Growth Factor beta | 3 | 2008 | 455 | 0.040 |
Why?
| | Species Specificity | 2 | 2016 | 574 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 138 | 0.040 |
Why?
| | Phenotype | 3 | 2019 | 3074 | 0.040 |
Why?
| | Proteasome Inhibitors | 1 | 2020 | 42 | 0.040 |
Why?
| | Arthritis, Rheumatoid | 1 | 2009 | 1097 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2019 | 2117 | 0.040 |
Why?
| | Bacteroides | 1 | 2019 | 19 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2019 | 2703 | 0.040 |
Why?
| | B7-2 Antigen | 2 | 2013 | 27 | 0.040 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 1999 | 21 | 0.040 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1999 | 26 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2019 | 7055 | 0.040 |
Why?
| | Ganglia | 1 | 2019 | 17 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1691 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 770 | 0.040 |
Why?
| | HLA-DQ beta-Chains | 1 | 2019 | 61 | 0.040 |
Why?
| | Macrophages, Peritoneal | 1 | 2019 | 92 | 0.040 |
Why?
| | Spondylarthritis | 1 | 2019 | 45 | 0.040 |
Why?
| | Survival Rate | 2 | 2017 | 1869 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2010 | 82 | 0.040 |
Why?
| | Coinfection | 1 | 2020 | 131 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 109 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 223 | 0.040 |
Why?
| | Genetic Loci | 1 | 2019 | 275 | 0.030 |
Why?
| | Protein Transport | 1 | 2019 | 428 | 0.030 |
Why?
| | Antigen-Presenting Cells | 1 | 2017 | 151 | 0.030 |
Why?
| | Cell Communication | 1 | 2018 | 300 | 0.030 |
Why?
| | Virus Diseases | 1 | 2019 | 210 | 0.030 |
Why?
| | Adventitia | 1 | 2016 | 43 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 275 | 0.030 |
Why?
| | Membrane Glycoproteins | 2 | 2013 | 476 | 0.030 |
Why?
| | Sheep | 1 | 1999 | 838 | 0.030 |
Why?
| | Life Style | 1 | 2018 | 459 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 300 | 0.030 |
Why?
| | Spermatozoa | 1 | 2016 | 91 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2019 | 586 | 0.030 |
Why?
| | Neuroglia | 1 | 2016 | 163 | 0.030 |
Why?
| | Virulence | 1 | 1996 | 255 | 0.030 |
Why?
| | Retroviridae | 1 | 2015 | 99 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 327 | 0.030 |
Why?
| | Vero Cells | 1 | 2015 | 65 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 5736 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 833 | 0.030 |
Why?
| | HIV Antigens | 1 | 2015 | 17 | 0.030 |
Why?
| | Immobilized Proteins | 1 | 2015 | 10 | 0.030 |
Why?
| | Neutralization Tests | 1 | 2015 | 73 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2019 | 320 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 665 | 0.030 |
Why?
| | Blood Cells | 1 | 2014 | 39 | 0.030 |
Why?
| | Mice, Nude | 1 | 1996 | 682 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2016 | 176 | 0.030 |
Why?
| | Autoantibodies | 1 | 2022 | 1467 | 0.030 |
Why?
| | Lymphocyte Subsets | 1 | 2014 | 84 | 0.030 |
Why?
| | Safety | 1 | 2016 | 330 | 0.030 |
Why?
| | Extracellular Space | 1 | 2015 | 120 | 0.030 |
Why?
| | Global Health | 1 | 2017 | 327 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 958 | 0.030 |
Why?
| | Endotoxemia | 1 | 2015 | 86 | 0.030 |
Why?
| | Endostatins | 1 | 2013 | 10 | 0.030 |
Why?
| | Activins | 1 | 2013 | 27 | 0.030 |
Why?
| | Integrin alphaVbeta3 | 1 | 2013 | 19 | 0.030 |
Why?
| | Colitis | 1 | 2016 | 241 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 275 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1835 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2013 | 52 | 0.030 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 107 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2017 | 631 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 119 | 0.030 |
Why?
| | B7-1 Antigen | 1 | 2013 | 61 | 0.030 |
Why?
| | Recurrence | 1 | 2016 | 1005 | 0.030 |
Why?
| | DNA, Viral | 1 | 2015 | 349 | 0.030 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2013 | 37 | 0.030 |
Why?
| | Lymphokines | 1 | 2013 | 127 | 0.030 |
Why?
| | Models, Immunological | 1 | 2013 | 95 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 21 | 0.030 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2013 | 102 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 812 | 0.030 |
Why?
| | Prednisone | 1 | 2014 | 233 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 199 | 0.030 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 157 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2013 | 83 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2013 | 262 | 0.020 |
Why?
| | Interleukin-15 | 1 | 2013 | 82 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 841 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1304 | 0.020 |
Why?
| | Fibroblasts | 1 | 2016 | 948 | 0.020 |
Why?
| | Severity of Illness Index | 2 | 2010 | 2740 | 0.020 |
Why?
| | Peritoneum | 1 | 2011 | 41 | 0.020 |
Why?
| | Lymphoid Tissue | 1 | 2011 | 67 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2015 | 848 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 530 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6391 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2010 | 43 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2011 | 160 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2011 | 122 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1266 | 0.020 |
Why?
| | Glioblastoma | 1 | 2013 | 322 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2016 | 1063 | 0.020 |
Why?
| | Valproic Acid | 1 | 2010 | 47 | 0.020 |
Why?
| | Antibody Formation | 1 | 2011 | 291 | 0.020 |
Why?
| | CD3 Complex | 1 | 2010 | 103 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2010 | 316 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2014 | 578 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2011 | 333 | 0.020 |
Why?
| | Radiation Chimera | 1 | 2009 | 30 | 0.020 |
Why?
| | Radiation Injuries, Experimental | 1 | 2009 | 23 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 854 | 0.020 |
Why?
| | Mice, Inbred DBA | 1 | 2009 | 190 | 0.020 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2008 | 5 | 0.020 |
Why?
| | Liver | 2 | 2007 | 1839 | 0.020 |
Why?
| | Bone Resorption | 1 | 2009 | 80 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2063 | 0.020 |
Why?
| | Research | 1 | 2011 | 416 | 0.020 |
Why?
| | Alleles | 2 | 2003 | 845 | 0.020 |
Why?
| | Remission, Spontaneous | 1 | 2007 | 37 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 3710 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2008 | 113 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2054 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 275 | 0.020 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2007 | 17 | 0.020 |
Why?
| | Precision Medicine | 1 | 2011 | 386 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2007 | 110 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 221 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2007 | 169 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2007 | 54 | 0.020 |
Why?
| | Blood | 1 | 2007 | 105 | 0.020 |
Why?
| | Cystatin C | 1 | 2006 | 65 | 0.020 |
Why?
| | CD8 Antigens | 1 | 2006 | 76 | 0.020 |
Why?
| | Fibrosis | 1 | 2009 | 520 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2007 | 212 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2006 | 192 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2008 | 263 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 5384 | 0.020 |
Why?
| | Bacillus subtilis | 1 | 2006 | 65 | 0.020 |
Why?
| | Gene Silencing | 1 | 2007 | 190 | 0.020 |
Why?
| | Thymus Gland | 1 | 2007 | 308 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 6543 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2007 | 312 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 374 | 0.020 |
Why?
| | Immunity, Cellular | 1 | 2007 | 265 | 0.020 |
Why?
| | Infant | 1 | 2019 | 8975 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2499 | 0.010 |
Why?
| | Brain | 1 | 2016 | 2669 | 0.010 |
Why?
| | Child, Preschool | 1 | 2019 | 10459 | 0.010 |
Why?
| | Aging | 1 | 2014 | 1774 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2007 | 1290 | 0.010 |
Why?
| | Clone Cells | 1 | 2003 | 262 | 0.010 |
Why?
| | HLA-DRB1 Chains | 1 | 2003 | 108 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 227 | 0.010 |
Why?
| | CD40 Antigens | 1 | 2002 | 88 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2013 | 1894 | 0.010 |
Why?
| | Consensus Sequence | 1 | 1999 | 73 | 0.010 |
Why?
| | Child | 1 | 2019 | 20785 | 0.010 |
Why?
| | Germ Cells | 1 | 1999 | 59 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 271 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 332 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 372 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 525 | 0.010 |
Why?
| | Disease Progression | 1 | 2005 | 2630 | 0.010 |
Why?
| | Protein Binding | 1 | 2003 | 2120 | 0.010 |
Why?
| | Opportunistic Infections | 1 | 1996 | 46 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1999 | 1036 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1999 | 639 | 0.010 |
Why?
| | Base Sequence | 1 | 1999 | 2146 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2056 | 0.010 |
Why?
| | Genetic Variation | 1 | 1999 | 938 | 0.010 |
Why?
|
|
Palmer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|